- Home
- TXMD vs DEVS Comparison
TXMD vs DEVS Comparison
Compare TXMD & DEVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- DEVS
- Stock Information
- Founded
- TXMD 2008
- DEVS N/A
- Country
- TXMD United States
- DEVS Canada
- Employees
- TXMD N/A
- DEVS N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- DEVS
- Sector
- TXMD Health Care
- DEVS
- Exchange
- TXMD Nasdaq
- DEVS NYSE
- Market Cap
- TXMD 13.5M
- DEVS 11.9M
- IPO Year
- TXMD N/A
- DEVS N/A
- Fundamental
- Price
- TXMD $1.14
- DEVS $0.43
- Analyst Decision
- TXMD
- DEVS
- Analyst Count
- TXMD 0
- DEVS 0
- Target Price
- TXMD N/A
- DEVS N/A
- AVG Volume (30 Days)
- TXMD 30.4K
- DEVS 722.8K
- Earning Date
- TXMD 07-30-2025
- DEVS 07-29-2025
- Dividend Yield
- TXMD N/A
- DEVS N/A
- EPS Growth
- TXMD N/A
- DEVS N/A
- EPS
- TXMD N/A
- DEVS N/A
- Revenue
- TXMD $1,841,000.00
- DEVS $10,164.00
- Revenue This Year
- TXMD $427.09
- DEVS N/A
- Revenue Next Year
- TXMD N/A
- DEVS N/A
- P/E Ratio
- TXMD N/A
- DEVS N/A
- Revenue Growth
- TXMD 53.55
- DEVS N/A
- 52 Week Low
- TXMD $0.70
- DEVS $0.18
- 52 Week High
- TXMD $2.44
- DEVS $3.00
- Technical
- Relative Strength Index (RSI)
- TXMD 43.84
- DEVS N/A
- Support Level
- TXMD $1.07
- DEVS N/A
- Resistance Level
- TXMD $1.24
- DEVS N/A
- Average True Range (ATR)
- TXMD 0.08
- DEVS 0.00
- MACD
- TXMD 0.00
- DEVS 0.00
- Stochastic Oscillator
- TXMD 59.62
- DEVS 0.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About DEVS DEVVSTREAM CORP
DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.